IPA Announces Closing of $1.265 Million Public Offering of Common Shares
ImmunoPrecise Antibodies Ltd. , today announced the closing of its $1.265 million underwritten public offering of 1,265,000 common shares, including 165,000 common shares issued pursuant to the full...